PROCHLORPERAZINE EDISYLATE Drug Patent Profile
✉ Email this page to a colleague
When do Prochlorperazine Edisylate patents expire, and what generic alternatives are available?
Prochlorperazine Edisylate is a drug marketed by Morton Grove, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Teva Parenteral, Viwit Pharm, Watson Labs, Wyeth Ayerst, and Alpharma Us Pharms. and is included in twenty-three NDAs.
The generic ingredient in PROCHLORPERAZINE EDISYLATE is prochlorperazine edisylate. There are twenty-one drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine Edisylate
A generic version of PROCHLORPERAZINE EDISYLATE was approved as prochlorperazine edisylate by HIKMA on August 29th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROCHLORPERAZINE EDISYLATE?
- What are the global sales for PROCHLORPERAZINE EDISYLATE?
- What is Average Wholesale Price for PROCHLORPERAZINE EDISYLATE?
Summary for PROCHLORPERAZINE EDISYLATE
US Patents: | 0 |
Applicants: | 18 |
NDAs: | 23 |
Finished Product Suppliers / Packagers: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 35 |
Patent Applications: | 348 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROCHLORPERAZINE EDISYLATE at DailyMed |
![PROCHLORPERAZINE EDISYLATE drug patent expirations Drug patent expirations by year for PROCHLORPERAZINE EDISYLATE](/p/graph/s/t/PROCHLORPERAZINE_EDISYLATE-patent-expirations.png)
Pharmacology for PROCHLORPERAZINE EDISYLATE
Drug Class | Phenothiazine |